US Broker Ratings

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 19.66% ROE and Robust Growth Prospects

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology firm, is capturing significant investor attention with its innovative approach to genetic medicine. With a market capitalization of..

Regencell Bioscience Holdings (RGC) Stock Analysis: Deciphering the Volatility and Growth Potential in Healthcare

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), operates in the healthcare sector, specifically within the drug manufacturing..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader with 19% Upside Potential

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, earning a reputation as a robust player in the medical care facilities industry...

Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating a 434% Revenue Surge and Strategic Clinical Trials

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering player in the biotechnology sector, is making significant waves with its innovative approach to RNA therapeutics. Based in San..

Labcorp Holdings Inc. (LH) Stock Analysis: 19% Potential Upside and Robust Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, continues to capture investor attention with its promising upside potential and strong analyst sentiment...

Viatris Inc. (VTRS) Stock Analysis: Navigating a Challenging Landscape with a 3.85% Dividend Yield

Viatris Inc. (NASDAQ: VTRS) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a substantial market..

BeOne Medicines Ltd. (ONC) Stock Report: A 28.63% Upside Potential in Revolutionary Cancer Treatments

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing investor attention with its substantial market capitalization of $34.42 billion and a promising..

BrightSpring Health Services (BTSG) Stock Analysis: A Healthcare Powerhouse with a 9.20% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a significant player in the healthcare sector, specifically in the health information services industry, is capturing investor attention due to its..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Promising 40% Upside with Biotech Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with its innovative approach to treating debilitating diseases through muscle activators and inhibitors. With a..

argenx SE (ARGX) Stock Analysis: Exploring a 19.98% Potential Upside in the Biotech Sector

Investors seeking opportunities in the rapidly evolving biotechnology sector may want to keep an eye on argenx SE (NYSE: ARGX). This Netherlands-based biopharmaceutical company, with a..

TransMedics Group, Inc. (TMDX) Investor Outlook: Strong Buy Ratings and a Promising 17.96% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering player in the medical devices industry, is capturing investor attention with its innovative technologies and promising financial trajectory. Based..

Vertex Pharmaceuticals (VRTX) Investor Outlook: Analyzing a Promising 8.8% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) remains a compelling prospect for investors eyeing the biotechnology sector. With a market capitalization of $115.92 billion, Vertex stands as a..

Nuvalent, Inc. (NUVL) Stock Analysis: A 40% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. Operating within..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Uncovering a 23.60% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization..

Solventum Corporation (SOLV): Investor Outlook on 8.37% Potential Upside

Solventum Corporation (NYSE: SOLV) has captured the attention of investors with its prominent position in the healthcare sector. With a market capitalization of $13.71 billion, Solventum..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 16.24% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a major player in the healthcare sector’s medical instruments and supplies industry, commands attention with a market capitalization of $7.81 billion. The..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Promising RAS-Targeted Therapies and a 5.37% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) has been making waves in the biotechnology sector with its innovative approach to treating RAS-addicted cancers. As a clinical-stage precision oncology..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a 23.2% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with a robust revenue growth of 23.2%. As a healthcare technology company, Oscar Health..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth and Valuation Challenges

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, has been a focal point of investor interest due to its involvement in..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 24.76% Potential Upside with Strong Buy Ratings

iRhythm Technologies, Inc. (IRTC), a leading player in the healthcare sector specializing in medical devices, is attracting significant investor attention due to its innovative cardiac monitoring..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds